ARDELYX, INC. Available-for-sale Securities, Amortized Cost Basis
ARDELYX, INC. (ARDX) had Available-for-sale Securities, Amortized Cost Basis of $10.87 million as of 2019-09-30, per its 10-Q filed 2019-11-06.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesAmortizedCost · last filed 2019-11-06
- 2019-09-30: Available-for-sale Securities, Amortized Cost Basis $10.87M.
- 2019-06-30: Available-for-sale Securities, Amortized Cost Basis $34.30M.
- 2019-03-31: Available-for-sale Securities, Amortized Cost Basis $59.51M.
- 2018-12-31: Available-for-sale Securities, Amortized Cost Basis $89.36M.
| Period end | Available-for-sale Securities, Amortized Cost Basis |
|---|---|
| 2019-09-30 | $10.87M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $34.30M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $59.51M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $89.36M 10-Q · filed 2019-11-06 |
| 2018-09-30 | $111.41M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $121.02M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $59.79M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $58.64M 10-K · filed 2019-03-06 |
| 2017-09-30 | $69.84M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $85.13M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $102.26M 10-Q · filed 2017-05-05 |
| 2016-12-31 | $126.30M 10-K · filed 2018-03-14 |
| 2016-09-30 | $69.75M 10-Q · filed 2016-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |